ABC | Volume 115, Nº1, Suplement, July 2020

Case Report Souto et al. SCAD in a patient with CTX Arq Bras Cardiol 2020; 115(1Suppl.1):18-21 Sousa AC; Critical revision of the manuscript for intellectual content: Almeida-Santos MA, Oliveira JLM, Sousa AC. Potential Conflict of Interest The authors report no conflict of interest concerning the materials and methods used in this study or the findings specified in this paper. Sources of Funding There was no external funding source for this study. Study Association This study is not associated with any thesis or dissertation. Ethics approval and consent to participate This study was approved by the Ethics Committee of the Universidade Federal de Sergipe under the protocol number CAAE: 0289.0.107.000-11. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study. 1. Mo g h a d a s i a n MH , S a l e n G , Fr o h l i c h J J, S c u d amo r e CH . Cerebrotendinous Xanthomatosis. Arch Neurol. 2002;59(4):527-9. 2. Pilo-de-la-Fuente B, Jimenez-Escrig A, Lorenzo JR, Pardo J, Arias M, Ares-Luque A, et al. Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol. 2011;18(10):1203 -11. 3. Tibrewal S, Duell PB, DeBarber AE, Loh AR. Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts. J Am Assoc Pediatr Ophthalmol Strabismus 2017;21(3):505–7. 4. Nie S, Chen G, Cao X, Zhang Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014;9(9) 1-11. 5. Passaseo I, Cacciotti L, Pauselli L, Ansalone G. Acute myocardial infarction in patient with cerebrotendinous xanthomatosis: Should these patients undergo stress tests during screening? J Cardiovasc Med. 2012;13(4):281–3. 6. Yip A, Saw J. Spontaneous coronary artery dissection-A review. Cardiovasc Diagn Ther 2015;5(1):37–48. 7. Alfonso F, Bastante T, Rivero F, Cuesta J, Benedicto A, Saw J, Gulati R. Spontaneous Coronary Artery Dissection. Circ J 2014;78(9):2099–110. 8. Lorincz MT, Rainier S, Thomas D, Fink JK. Cerebrotendinous Xanthomatosis. Arch Neurol 2005;62(9):1459-63. 9. Salen G, DeBarber A, Eichler F, Casaday L, Jayadev S, Kisanuki Y, et al. The Diagnosis and Treatment of Cerebrotendinous Xanthomatosis. J Clin Lipidol. 2018;12(5):545–6. 10. Duell PB, Salen G, Eichler FS, DeBarber AE, Connor SL, Casaday L, et al. Diffenderfer MR, Schaefer EJ. Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis. J Clin Lipidol. 2018;12(5):1169–78. 11. Fujiyama J, Kuriyama M, Arima S, Shibata Y, Nagata K, Takenaga S, et al. Atherogenic risk factors in cerebrotendinous xanthomatosis. Clin Chim Acta. 1991;200(1):1–11. 12. Sekijima Y, Koyama S, Yoshinaga T, Koinuma M, Inaba Y. Nationwide survey on cerebrotendinous xanthomatosis in Japan. J Hum Genet. 2018;63(3):271–80. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 21